Frontlight ResearchEarly access
Ankylosing spondylitis trials in United States
8 of 16 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Where
- Albuquerque, Apple Valley, Baytown, Beckley, Bellevue, Chicago, Colleyville, Covina, Duncansville, Fort Collins, Fullerton, Jackson, Lansing, Mesquite, Murfreesboro, Ormond Beach, Peoria, Plano, Riverside, Rock Hill, San Leandro, South Miami, Spokane, Temecula, Upland, Vandalia, West Long Branch, Whittier, Zephyrhills
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07290036 - No phaseTaking peopleRENEW Intervention for Axial Spondyloarthritis
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 40
- Run by
- University of Michigan
See details and how to joinNCT07836374 - Phase 4Not yet taking people in United StatesA Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- The University of Texas Health Science Center, Houston
See details and how to joinNCT07770646 - Phase 1Taking peopleA Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Where
- Boston, Chapel Hill, Durham, Milwaukee, Santa Monica, South Miami
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00 - Phase 2Taking peopleImmunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Where
- New York
- Age
- 18 years and over
- People
- 80
- Run by
- NYU Langone Health
See details and how to joinNCT07138898 - No phaseTaking peoplePhysical Activity Through Health Technology in Axial Spondyloarthritis
- Where
- Seattle
- Age
- 18 years and over
- People
- 40
- Run by
- University of Washington
See details and how to joinNCT07642622 - Phase 4Taking peopleA Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- Where
- Cleveland, Philadelphia, Portland
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00 - Phase 4Not yet taking people in United StatesImpact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT07018206 · EU 2025-522118-21-00